The road to a successful pharma product launch is paved with pitfalls and there are some common problems that big pharma has faced in the past when it comes to drug launches.
0 Comments Click here to read/write comments
Topics: 2017 trends, Pharma launch planning, Pharma trends, Market access
The commercial model in pharma has shifted in response to the end of the blockbuster era, the ‘patent cliff’, formidable competition from generics, rapid growth in emerging markets, and a new challenging and complex payer environment with increasing market access restrictions. Together, they have shaped a new paradigm of pharma launch readiness for an era where the blockbuster approach is no longer suitable.
0 Comments Click here to read/write comments
Topics: 2017 trends, Pharma launch planning, Pharma trends, Market access